materials rutendo kuwana technical officer, who, geneva training workshop: training workshop on...
TRANSCRIPT
Materials
Rutendo Kuwana
Technical Officer, WHO, Geneva
Training workshop: Training workshop on regulatory requirements for registration of Artemisinin based combined medicines and assessment of data submitted to regulatory authorities, February 23-27, 2009, Kampala, Uganda.
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 2 |
Basic Principles of GMPBasic Principles of GMP
Materials
14
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 3 |
MaterialsMaterials
Objectives To review specific requirements for each type of material:
Starting materials Packaging materials Intermediate and bulk products Finished products Rejected and recovered materials Recalled products Returned goods Reagents and culture media Reference standards Waste materials Miscellaneous materials
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 4 |
MaterialsMaterials
Principle
Objective of the pharmaceutical manufacturer produce finished products for patient's use from a
combination of materials
Materials combined Active pharmaceutical ingredients and Excipients (auxiliary materials) Packaging materials
Materials include also Gases, solvents, reagents, process aids, etc. Special attention 14.1, 14.2
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 5 |
14.3–14.6
MaterialsMaterials
General requirements for materials
Materials for cleaning, lubrication, and pest control Not in direct contact with product Suitable grade, e.g. food grade if possible
All incoming materials and finished products quarantined after receipt or processing
– until released for use or distribution stored
– under appropriate conditions– orderly fashion (batch segregation)– materials management– stock rotation (FEFO)
Water – suitable for use
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 6 |
14.7 – 14.10
MaterialsMaterials
Starting Materials – I
Purchasing – important operation From approved suppliers – if possible, direct from the
manufacturerSpecifications for materialsConsignment checks
Integrity of package Seal intact Corresponds with the purchase order Delivery note Supplier’s labels
Cleaned and labelled with information
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 7 |
Supplier EvaluationSupplier Evaluation
Historical experience
Questionnaire – including reputation within industry, availability of certificates e.g. ISO 9000 certificates, GMP
Check/compare own analytical results e.g. three batches/shipments with suppliers CoA
Site audit of supplier (case by case basis)
Name and address of manufacturer of critical material must always be known
Changes in source (manufacturer or supplier) of critical material should be handled according to Change Control procedure
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 8 |
14.11 – 14.14
MaterialsMaterials
Starting Materials – II
Different batches in one delivery/consignment
Starting materials labelled name and internal code Supplier's batch number(s) and manufacturer's on receipt Status (e.g. quarantine, on test, etc.) expiry date or retest date
Role of validated computer systems
"Sampled" containers identified
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 9 |
Basic Principles of GMPBasic Principles of GMP
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 10 |
Sampling and TestingSampling and Testing
Sampling plans should be scientifically sound (not just statistically based) and appropriate for material being sampled.
They must also be practical/easy to use - obtain a representative sample
Should be based on Risk Assessment
• Criticality of the material
• Manufacturers/suppliers quality system and manufacturing process
• Historical data
• Homogeneity
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 11 |
Basic Principles of GMPBasic Principles of GMP
Damage to and problems with containers Recorded and reported
to QC Investigated
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 12 |
MaterialsMaterials
Examples of Labelling of Starting Materials
Name of Material and/ or internal code
Control/ Batch No.
Status Quarantined/Released/Rejected
(Colours may be used)
Expiry date or retest date
Date Signature
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 13 |
14.15 – 14.18
MaterialsMaterials
Starting Materials – III
Use only QC released material if within shelf-lifeDispensing
designated persons written procedure Correct materials accurately weighed clean, properly labelled containers
Independent checks and record material and weight or volume
Dispensed material kept together and labelled
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 14 |
Basic Principles of GMPBasic Principles of GMP
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 15 |
14.25–14.20
MaterialsMaterials
Packaging materials - I
Primary and printed packaging materials purchasing, handling and control
– as for starting materialsPrinted packaging materials: particular attention
Stored in secure conditions with authorized access Roll labels where possible in place of cut labels Loose materials stored and transported in separate, closed
containers - to avoid mix-ups Issued by designated personnel SOP for issue and returns
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 16 |
Basic Principles of GMPBasic Principles of GMP
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 17 |
14.21 – 14.23
MaterialsMaterials
Printed and primary packaging materials - II
Each delivery or batch: specific reference number or identification mark
Delivery to packaging department Check quantity, identity and conformity to packaging
instructions
Outdated or obsolete material Destroyed Disposal record
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 18 |
Basic Principles of GMPBasic Principles of GMP
Intermediate and bulk products
Kept under appropriate conditions
If purchased as such Handled on receipt as
though these are starting materials
14.24 – 14.25
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 19 |
Basic Principles of GMPBasic Principles of GMP
Finished products
Held in quarantine until their final release
Then stored as usable stock under suitable storage conditions
Evaluation and documentation necessary for release
Product release procedure
Batch record review and related procedure
14.26 – 14.27
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 20 |
14.28
MaterialsMaterials
Rejected, reworked and recovered materials
Rejected materials and products Clearly marked Stored separately in restricted areas Action – returned to supplier/destroyed, etc. in timely manner Action approved by authorized personnel – records
maintained
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 21 |
14.29 – 14.30
MaterialsMaterials
Rejected, reworked and recovered materials
Rework and recovery Should be exceptional cases Only if:
– Risks involved have been evaluated and the quality of final product will not be affected
– Specifications are met– Defined procedure– Records maintained– New batch number
additional testing to be considered by QC
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 22 |
14.32 – 14.33
MaterialsMaterials
Recalled products and returned goods
Recalled products Identified Stored separately Secure area - access controlled Decision taken on their fate
Returned goods Destroyed unless suitable quality SOP: decision regarding their fate (relabelling, resale, etc.)
– Consider: nature of product, special storage conditions, condition, history, time elapsed since issue
Action taken to be recorded
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 23 |
14.34 – 14.36
MaterialsMaterials
Reagents and culture media
Records for receipt or preparationReagents
Preparation in accordance with SOP Appropriately labelled:
– concentration, standardization factor, shelf-life, date that restandardization is due, storage conditions
– signed and datedCulture media
positive and negative controls each time prepared and used Inoculum size appropriate
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 24 |
14.37 – 14.40, 14.42
MaterialsMaterials
Reference standards - I
Official reference standards Use preferable whenever these exist Only for the purpose as per monograph Storage conditions
Reference standards prepared by the producer Tested, released and stored in the same way as official
standards In a secure area A responsible person
Secondary or working standards Appropriate checks and tests at regular intervals Standardized against official reference standards – initially and
at regular intervals
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 25 |
14.41, 14.43
MaterialsMaterials
Reference standards - II
Reference standards labelled with information including Name Batch, lot or control number Date of preparation Shelf-life Potency Storage conditions
Stored and used in an appropriate manner
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 26 |
14.44
MaterialsMaterials
Waste materials
Waste materials proper and safe storage when awaiting disposal toxic substances and flammable materials:
– in suitably designed, separate, enclosed areas as per national legislation
not to be allowed to accumulate– collected in suitable containers for removal to collection
points– safe and sanitary disposal– regular and frequent intervals
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 27 |
14.45
MaterialsMaterials
Miscellaneous materials
Miscellaneous Rodenticides, insecticides, fumigating agents Sanitizing material No contamination risk to equipment, starting materials,
packaging materials, in-process materials, finished products
Artemisinin based combined medicinesFebruary 23-27, 2009, Kampala, Uganda 28 |
MaterialsMaterials
Group session
List specific aspects of GMP requirements, in relation to the groups of materials listed below, that you would assess when inspecting a manufacturer Printed packaging materials Thermolabile materials Water Sterile materials
Identify three materials that present problems in your experience
What are some of the problems that you have experienced before and during inspection of materials?